Gender equality index 2023

The French law on the freedom to choose one’s professional future of September 5, 2018 makes equal pay for men and women an obligation of result for companies. In particular, it requires them to measure their gender equality index every year in order to assess pay gaps on the basis of several indicators. In the […]

The Open-Source Revolution of AliBERT in French Biomedical AI

Developed by Quinten in 2022, AliBERT is a specialized model focusing on the French biomedical language. One version has been released as an open-source tool on the Huggingface platform, marking a significant contribution to the field of natural language processing (NLP) in healthcare.

AliBERT achieves it first successful application in oncology!

A successful proof-of-concept for AliBERT, the first French-language model specialized in the biomedical field. In partnership with a major French Cancer Fighting Institute, Quinten’s datalab team has developed a first concrete use case : the extraction of concepts and structured information from medical reports in oncology. A Natural Language Processing [NLP] task which, until now, has been highly complex, given the technical nature, diversity and specialization of these medical reports.

“Securing & accelerating clinical development and market access for therapeutic innovations using Real-World disease and care modeling and simulation”

Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table organized by E4i. The theme of the round table was innovative therapies related to precision medicine. Alexandre Templier spoke about how real-world data (RWD) is set to revolutionize the clinical development and market […]

Horizon Europe: Quinten Health into More-EUROPA’s project for more RWD

Quinten Health is participating in the More-EUROPA project in the framework of the Horizon Europe program. The latter funds projects aiming to develop “new methods for the effective use of real-life data and/or synthetic data in regulatory decision-making and/or health technology assessment”. With a duration of 5 years, More-Europa [MORE Effective and ethical Use of […]

Big Data: a new therapeutic option? Part 6: AI-augmented health

From Data to Artificial Intelligence in healthcare Following Part 5: The future of pharma 6) From Data to Artificial Intelligence Big Data will undoubtedly play a central role in the new relationship that Man will soon have with his well-being, his health and his aging process. Beyond the “quantified self” and connected health, which will […]